CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2024	$ 407,976	$ 7	$ 951,519	$ 674	$ (544,224)
Beginning Balance, Shares at Dec. 31, 2024		70,645,139
Issuance of common stock upon vesting of restricted stock units, Shares		312,415
Share-based compensation expense	2,834		2,834
Net unrealized gain (loss) on investments	(22)			(22)
Net loss	(31,983)				(31,983)
Ending Balance at Mar. 31, 2025	378,805	$ 7	954,353	652	(576,207)
Ending Balance, Shares at Mar. 31, 2025		70,957,554
Beginning Balance at Dec. 31, 2024	407,976	$ 7	951,519	674	(544,224)
Beginning Balance, Shares at Dec. 31, 2024		70,645,139
Net loss	(76,675)
Ending Balance at Sep. 30, 2025	337,900	$ 7	958,256	536	(620,899)
Ending Balance, Shares at Sep. 30, 2025		71,024,512
Beginning Balance at Mar. 31, 2025	$ 378,805	$ 7	$ 954,353	652	(576,207)
Beginning Balance, Shares at Mar. 31, 2025		70,957,554
Issuance of common stock upon vesting of restricted stock units, Shares		14,827
Common stock issued under employee stock purchase plan, Shares	77,000	52,131	77,000
Share-based compensation expense	$ 2,053		$ 2,053
Net unrealized gain (loss) on investments	(290)			(290)
Net loss	(22,977)				(22,977)
Ending Balance at Jun. 30, 2025	357,668	$ 7	956,483	362	(599,184)
Ending Balance, Shares at Jun. 30, 2025		71,024,512
Share-based compensation expense	1,773		1,773
Net unrealized gain (loss) on investments	174			174
Net loss	(21,715)				(21,715)
Ending Balance at Sep. 30, 2025	337,900	$ 7	958,256	536	(620,899)
Ending Balance, Shares at Sep. 30, 2025		71,024,512
Beginning Balance at Dec. 31, 2025	312,325	$ 7	960,219	407	(648,308)
Beginning Balance, Shares at Dec. 31, 2025		71,078,531
Issuance of common stock upon exercise of stock options	6		6
Issuance of common stock upon exercise of stock options, Shares		3,719
Issuance of common stock upon vesting of restricted stock units, Shares		208,240
Share-based compensation expense	1,898		1,898
Net unrealized gain (loss) on investments	(537)			(537)
Net loss	(27,832)				(27,832)
Ending Balance at Mar. 31, 2026	285,860	$ 7	962,123	(130)	(676,140)
Ending Balance, Shares at Mar. 31, 2026		71,290,490
Beginning Balance at Dec. 31, 2025	312,325	$ 7	960,219	407	(648,308)
Beginning Balance, Shares at Dec. 31, 2025		71,078,531
Net loss	(101,526)
Ending Balance at Sep. 30, 2026	215,749	$ 7	966,572	(996)	(749,834)
Ending Balance, Shares at Sep. 30, 2026		71,704,404
Beginning Balance at Mar. 31, 2026	285,860	$ 7	962,123	(130)	(676,140)
Beginning Balance, Shares at Mar. 31, 2026		71,290,490
Issuance of common stock upon exercise of stock options	$ 603		$ 603
Issuance of common stock upon exercise of stock options, Shares		274,306
Issuance of common stock upon vesting of restricted stock units, Shares		10,570
Common stock issued under employee stock purchase plan, Shares	73,000	46,855	73,000
Share-based compensation expense	$ 1,865		$ 1,865
Net unrealized gain (loss) on investments	(295)			(295)
Net loss	(40,368)				(40,368)
Ending Balance at Jun. 30, 2026	247,738	$ 7	964,664	(425)	(716,508)
Ending Balance, Shares at Jun. 30, 2026		71,622,221
Issuance of common stock upon exercise of stock options	143		143
Issuance of common stock upon exercise of stock options, Shares		82,183
Share-based compensation expense	1,765		1,765
Net unrealized gain (loss) on investments	(571)			(571)
Net loss	(33,326)				(33,326)
Ending Balance at Sep. 30, 2026	$ 215,749	$ 7	$ 966,572	$ (996)	$ (749,834)
Ending Balance, Shares at Sep. 30, 2026		71,704,404